Literature DB >> 19140209

Effect of anticoagulants on the plasma hyaluronidase activities.

R Sharma1, Y H Mahadeswaraswamy, K Harish Kumar, S Devaraja, K Kemparaju, B S Vishwanath, K S Girish.   

Abstract

Mammalian hyaluronidases (HAases) are an endo-beta-N-acetyl-hexosaminidases that degrade hyaluronan (HA) and have been implicated in diverse pathophysiological functions. Several pathological conditions, such as diabetes, monoclonal gammapathy, and bladder and prostate tumors, report the distorted plasma HAase activity. However, the plasma HAase (hHyal-1) activity has been presumed to change with the circulating HA level and serves as an early marker for several diseases. It has been generally practised to use the anticoagulants such as tri-sodium citrate/di-sodium EDTA/heparin for the preparation of plasma for both biochemical and clinical analyses. In the present investigation, the effect of anticoagulants on plasma HAaseactivity was evaluated and compared with the serum HAase activity that is devoid of anticoagulants as no study provides information in this regard. The results suggested that the plasma HAase activity in the presence of the recommended concentration of EDTA was highly comparable/similar to that of the serum HAase activity. In contrast, citrated or heparinized plasma recorded a significantly reduced level of activity than that of the serum HAase activity. In conclusion, our results suggested that the EDTA-treated plasma samples are a better choice compared with heparin and citrated samples to assess the HAase activity. Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19140209      PMCID: PMC6648972          DOI: 10.1002/jcla.20285

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  23 in total

1.  Hyaluronidase activity in serum of patients with monoclonal gammapathy.

Authors:  A Laudat; J Guechot; K Lecourbe; R Damade; A M Palluel
Journal:  Clin Chim Acta       Date:  2000-11       Impact factor: 3.786

Review 2.  Clostridial hydrolytic enzymes degrading extracellular components.

Authors:  O Matsushita; A Okabe
Journal:  Toxicon       Date:  2001-11       Impact factor: 3.033

3.  A modified colorimetric method for the estimation of N-acetylamino sugars.

Authors:  J L REISSIG; J L STORMINGER; L F LELOIR
Journal:  J Biol Chem       Date:  1955-12       Impact factor: 5.157

Review 4.  Hyaluronan: from extracellular glue to pericellular cue.

Authors:  Bryan P Toole
Journal:  Nat Rev Cancer       Date:  2004-07       Impact factor: 60.716

Review 5.  Hyaluronidases: their genomics, structures, and mechanisms of action.

Authors:  Robert Stern; Mark J Jedrzejas
Journal:  Chem Rev       Date:  2006-03       Impact factor: 60.622

Review 6.  Hyaluronan and its catabolic products in tissue injury and repair.

Authors:  Paul W Noble
Journal:  Matrix Biol       Date:  2002-01       Impact factor: 11.583

7.  Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes.

Authors:  Max Nieuwdorp; Hans L Mooij; Jojanneke Kroon; Bektas Atasever; Jos A E Spaan; Can Ince; Frits Holleman; Michaela Diamant; Robert J Heine; Joost B L Hoekstra; John J P Kastelein; Erik S G Stroes; Hans Vink
Journal:  Diabetes       Date:  2006-04       Impact factor: 9.461

Review 8.  The magic glue hyaluronan and its eraser hyaluronidase: a biological overview.

Authors:  K S Girish; K Kemparaju
Journal:  Life Sci       Date:  2007-03-06       Impact factor: 5.037

Review 9.  Functions of hyaluronan in wound repair.

Authors:  W Y Chen; G Abatangelo
Journal:  Wound Repair Regen       Date:  1999 Mar-Apr       Impact factor: 3.617

10.  Serum hyaluronan and hyaluronidase: very early markers of toxic liver injury.

Authors:  Joseph George; Robert Stern
Journal:  Clin Chim Acta       Date:  2004-10       Impact factor: 3.786

View more
  1 in total

1.  Subtype specific elevated expression of hyaluronidase-1 (HYAL-1) in epithelial ovarian cancer.

Authors:  Paule Héléna Yoffou; Lydia Edjekouane; Liliane Meunier; André Tremblay; Diane Michèle Provencher; Anne-Marie Mes-Masson; Euridice Carmona
Journal:  PLoS One       Date:  2011-06-10       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.